Prescription and Over-The-Counter Drug Product List 38TH EDITION Cumulative Supplement Number 08 : August 2018 ADDITIONS/DELETIONS for PRESCRIPTION DRUG PRODUCT LIST

Home , Hydrocortisone phosphate

Prescription and Over-the-Counter Drug Product List 38TH EDITION Cumulative Supplement Number 08 : August 2018 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

ACETAMINOPHEN; CODEINE PHOSPHATE SOLUTION;ORAL ACETAMINOPHEN AND CODEINE PHOSPHATE >A> @ ACI HEALTHCARE LTD 120MG/5ML;12MG/5ML A 086366 001 Mar 27, 1979 Aug CAHN >D> @ ALLIED 120MG/5ML;12MG/5ML A 086366 001 Mar 27, 1979 Aug CAHN TABLET;ORAL ACETAMINOPHEN AND CODEINE PHOSPHATE >D> @ ANDA REPOSITORY 300MG;15MG A 089673 002 Feb 10, 1988 Aug CAHN >D> @ 300MG;30MG A 089673 003 Feb 10, 1988 Aug CAHN >D> @ 300MG;60MG A 089673 001 Feb 10, 1988 Aug CAHN >A> @ FRONTIDA BIOPHARM 300MG;15MG A 089673 002 Feb 10, 1988 Aug CAHN >A> @ 300MG;30MG A 089673 003 Feb 10, 1988 Aug CAHN >A> @ 300MG;60MG A 089673 001 Feb 10, 1988 Aug CAHN

ACETAMINOPHEN; HYDROCODONE BITARTRATE SOLUTION;ORAL HYDROCODONE BITARTRATE AND ACETAMINOPHEN >A> AA GENUS LIFESCIENCES 325MG/15ML;7.5MG/15ML A 040894 001 Jul 19, 2011 Aug CAHN >D> AA VINTAGE PHARMS 325MG/15ML;7.5MG/15ML A 040894 001 Jul 19, 2011 Aug CAHN

ACYCLOVIR SODIUM INJECTABLE;INJECTION ACYCLOVIR SODIUM >A> ZYDUS PHARMS USA INC EQ 500MG BASE/VIAL A 206535 001 Aug 31, 2018 Aug NEWA >A> EQ 1GM BASE/VIAL A 206535 002 Aug 31, 2018 Aug NEWA

ALBUTEROL SULFATE TABLET;ORAL ALBUTEROL SULFATE >D> AB APPCO PHARMA LLC EQ 2MG BASE A 207046 001 Jun 29, 2018 Aug CAHN >D> AB EQ 4MG BASE A 207046 002 Jun 29, 2018 Aug CAHN >A> AB RISING PHARMS EQ 2MG BASE A 207046 001 Jun 29, 2018 Aug CAHN >A> AB EQ 4MG BASE A 207046 002 Jun 29, 2018 Aug CAHN

ALBUTEROL SULFATE; IPRATROPIUM BROMIDE SOLUTION;INHALATION ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE >D> AN TEVA PHARMS EQ 0.083% BASE;0.017% A 076724 001 Dec 31, 2007 Aug DISC >A> @ EQ 0.083% BASE;0.017% A 076724 001 Dec 31, 2007 Aug DISC

ALENDRONATE SODIUM TABLET;ORAL ALENDRONATE SODIUM >D> AB DR REDDYS LABS LTD EQ 5MG BASE A 079049 003 Aug 04, 2008 Aug CAHN >D> AB EQ 10MG BASE A 079049 004 Aug 04, 2008 Aug CAHN >D> AB EQ 35MG BASE A 079049 001 Aug 04, 2008 Aug CAHN >D> AB EQ 70MG BASE A 079049 002 Aug 04, 2008 Aug CAHN >A> AB NEOPHARMA EQ 5MG BASE A 079049 003 Aug 04, 2008 Aug CAHN >A> AB EQ 10MG BASE A 079049 004 Aug 04, 2008 Aug CAHN >A> AB EQ 35MG BASE A 079049 001 Aug 04, 2008 Aug CAHN >A> AB EQ 70MG BASE A 079049 002 Aug 04, 2008 Aug CAHN

ALPRAZOLAM TABLET;ORAL ALPRAZOLAM >A> AB BRECKENRIDGE PHARM 0.25MG A 207507 001 Jul 09, 2018 Aug CAHN >A> AB 0.5MG A 207507 002 Jul 09, 2018 Aug CAHN >A> AB 1MG A 207507 003 Jul 09, 2018 Aug CAHN >A> AB 2MG A 207507 004 Jul 09, 2018 Aug CAHN >D> AB CENTAUR PHARMS PVT 0.25MG A 207507 001 Jul 09, 2018 Aug CAHN >D> AB 0.5MG A 207507 002 Jul 09, 2018 Aug CAHN >D> AB 1MG A 207507 003 Jul 09, 2018 Aug CAHN >D> AB 2MG A 207507 004 Jul 09, 2018 Aug CAHN

Page 1 of 23 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL TABLET;ORAL AMLODIPINE AND OLMESARTAN MEDOXOMIL >A> AB ACCORD HLTHCARE INC EQ 5MG BASE;20MG A 209600 001 Aug 30, 2018 Aug NEWA >A> AB EQ 5MG BASE;40MG A 209600 003 Aug 30, 2018 Aug NEWA >A> AB EQ 10MG BASE;20MG A 209600 002 Aug 30, 2018 Aug NEWA >A> AB EQ 10MG BASE;40MG A 209600 004 Aug 30, 2018 Aug NEWA

AMPICILLIN SODIUM INJECTABLE;INJECTION AMPICILLIN SODIUM >D> AP AUROBINDO PHARMA EQ 125MG BASE/VIAL A 065499 001 Aug 17, 2010 Aug DISC >A> @ EQ 125MG BASE/VIAL A 065499 001 Aug 17, 2010 Aug DISC

ANGIOTENSIN II ACETATE SOLUTION;INTRAVENOUS GIAPREZA >D> +! LA JOLLA PHARMA EQ 5MG BASE/2ML (EQ 2.5MG N 209360 002 Dec 21, 2017 Aug DISC BASE/ML) >A> + @ EQ 5MG BASE/2ML (EQ 2.5MG N 209360 002 Dec 21, 2017 Aug DISC BASE/ML)

APREPITANT >A> EMULSION;INTRAVENOUS >A> CINVANTI >A> +! HERON THERAPS INC 130MG/18ML (7.2MG/ML) N 209296 001 Nov 09, 2017 Aug CDFR >D> EMULSION;IV (INFUSION) >D> CINVANTI >D> +! HERON THERAPS INC 130MG/18ML (7.2MG/ML) N 209296 001 Nov 09, 2017 Aug CDFR

ARGATROBAN >A> INJECTABLE;INTRAVENOUS >A> ARGATROBAN IN 0.9% SODIUM CHLORIDE >A> TEVA PHARMS USA 250MG/250ML (1MG/ML) N 206769 001 Dec 15, 2014 Aug CDFR >A> ARGATROBAN IN SODIUM CHLORIDE >A> +! EAGLE PHARMS 50MG/50ML (1MG/ML) N 022434 001 Jun 29, 2011 Aug CDFR >A> AP GLAND PHARMA LTD 125MG/125ML (1MG/ML) A 205570 001 May 22, 2017 Aug CDFR >A> AP +! SANDOZ 125MG/125ML (1MG/ML) N 022485 001 May 09, 2011 Aug CDFR >D> INJECTABLE;IV (INFUSION) >D> ARGATROBAN IN 0.9% SODIUM CHLORIDE >D> TEVA PHARMS USA 250MG/250ML (1MG/ML) N 206769 001 Dec 15, 2014 Aug CDFR >D> ARGATROBAN IN SODIUM CHLORIDE >D> +! EAGLE PHARMS 50MG/50ML (1MG/ML) N 022434 001 Jun 29, 2011 Aug CDFR >D> AP GLAND PHARMA LTD 125MG/125ML (1MG/ML) A 205570 001 May 22, 2017 Aug CDFR >D> AP +! SANDOZ 125MG/125ML (1MG/ML) N 022485 001 May 09, 2011 Aug CDFR

ARIPIPRAZOLE TABLET, ORALLY DISINTEGRATING;ORAL ARIPIPRAZOLE >A> AB ZYDUS PHARMS USA INC 10MG A 090165 001 Aug 28, 2018 Aug NEWA >A> AB 15MG A 090165 002 Aug 28, 2018 Aug NEWA >A> 20MG A 090165 003 Aug 28, 2018 Aug NEWA >A> 30MG A 090165 004 Aug 28, 2018 Aug NEWA

ARSENIC TRIOXIDE INJECTABLE;INJECTION >A> ARSENIC TRIOXIDE >A> FRESENIUS KABI USA 1MG/ML A 208231 001 Aug 31, 2018 Aug NEWA

ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE; RIBOFLAVIN; THIAMINE; TOCOPHEROL ACETATE; VITAMIN A; VITAMIN K >A> INJECTABLE;INTRAVENOUS >A> INFUVITE PEDIATRIC >A> +! SANDOZ INC 80MG/VIAL;0.02MG/VIAL;400 N 021265 001 Feb 21, 2001 Aug CDFR IU/VIAL;0.001MG/VIAL;5MG/VIAL;0 .14MG/VIAL;17MG/VIAL;1MG/VIAL;1 .4MG/VIAL;1.2MG/VIAL;7 IU/VIAL;2,300 IU/VIAL;0.2MG/VIAL >A> INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE) >A> +! SANDOZ INC 80MG/VIAL;0.02MG/VIAL;400 N 021646 001 Jan 29, 2004 Aug CDFR IU/VIAL;0.001MG/VIAL;5MG/VIAL;0 .14MG/VIAL;17MG/VIAL;1MG/VIAL;

Page 2 of 23 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE; RIBOFLAVIN; THIAMINE; TOCOPHEROL ACETATE; VITAMIN A; VITAMIN K >A> INJECTABLE;INTRAVENOUS >A> INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE) 1.4MG/VIAL;1.2MG/VIAL;7 IU/VIAL;2,300 IU/VIAL;0.2MG/VIAL >D> INJECTABLE;IV (INFUSION) >D> INFUVITE PEDIATRIC >D> +! SANDOZ INC 80MG/VIAL;0.02MG/VIAL;400 N 021265 001 Feb 21, 2001 Aug CDFR IU/VIAL;0.001MG/VIAL;5MG/VIAL;0 .14MG/VIAL;17MG/VIAL;1MG/VIAL;1 .4MG/VIAL;1.2MG/VIAL;7 IU/VIAL;2,300 IU/VIAL;0.2MG/VIAL >D> INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE) >D> +! SANDOZ INC 80MG/VIAL;0.02MG/VIAL;400 N 021646 001 Jan 29, 2004 Aug CDFR IU/VIAL;0.001MG/VIAL;5MG/VIAL;0 .14MG/VIAL;17MG/VIAL;1MG/VIAL;1 .4MG/VIAL;1.2MG/VIAL;7 IU/VIAL;2,300 IU/VIAL;0.2MG/VIAL

ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PHYTONADIONE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E >A> FOR SOLUTION;INTRAVENOUS >A> M.V.I. PEDIATRIC >A> +! HOSPIRA 80MG/VIAL;0.02MG/VIAL;0.001MG/V N 018920 001 Sep 21, 2000 Aug CDFR IAL;5MG/VIAL;0.01MG/VIAL;0.14MG /VIAL;17MG/VIAL;0.2MG/VIAL;1MG/ VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL

>D> FOR SOLUTION;IV (INFUSION) >D> M.V.I. PEDIATRIC >D> +! HOSPIRA 80MG/VIAL;0.02MG/VIAL;0.001MG/V N 018920 001 Sep 21, 2000 Aug CDFR IAL;5MG/VIAL;0.01MG/VIAL;0.14MG /VIAL;17MG/VIAL;0.2MG/VIAL;1MG/ VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL

ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E; VITAMIN K >A> INJECTABLE;INTRAVENOUS >A> M.V.I. ADULT >A> +! HOSPIRA 200MG/VIAL;0.06MG/VIAL;0.005MG/ N 021625 001 Jan 30, 2004 Aug CDFR VIAL;15MG/VIAL;0.005MG/VIAL;0.6 MG/VIAL;40MG/VIAL;6MG/VIAL;3.6M G/VIAL;6MG/VIAL;1MG/VIAL;10MG/V IAL;0.15MG/VIAL >A> M.V.I. ADULT (PHARMACY BULK PACKAGE) >A> +! HOSPIRA 200MG/5ML;0.06MG/5ML;0.005MG/5M N 021643 001 Feb 18, 2004 Aug CDFR L;15MG/5ML;0.005MG/5ML;0.6MG/5M L;40MG/5ML;6MG/5ML;3.6MG/5ML;6M G/5ML;1MG/5ML;10MG/5ML;0.15MG/5 ML >D> INJECTABLE;IV (INFUSION) >D> M.V.I. ADULT >D> +! HOSPIRA 200MG/VIAL;0.06MG/VIAL;0.005MG/ N 021625 001 Jan 30, 2004 Aug CDFR VIAL;15MG/VIAL;0.005MG/VIAL;0.6 MG/VIAL;40MG/VIAL;6MG/VIAL;3.6M G/VIAL;6MG/VIAL;1MG/VIAL;10MG/V IAL;0.15MG/VIAL >D> M.V.I. ADULT (PHARMACY BULK PACKAGE) >D> +! HOSPIRA 200MG/5ML;0.06MG/5ML;0.005MG/5M N 021643 001 Feb 18, 2004 Aug CDFR L;15MG/5ML;0.005MG/5ML;0.6MG/5M L;40MG/5ML;6MG/5ML;3.6MG/5ML;6M G/5ML;1MG/5ML;10MG/5ML;0.15MG/5 ML

>D> ASPIRIN; CAFFEINE; DIHYDROCODEINE BITARTRATE >D> CAPSULE;ORAL >D> SYNALGOS-DC >D> +! SUN PHARM INDUSTRIES 356.4MG;30MG;16MG N 011483 004 Sep 06, 1983 Aug DISC >A> + @ 356.4MG;30MG;16MG N 011483 004 Sep 06, 1983 Aug DISC

Page 3 of 23 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

ASPIRIN; DIPYRIDAMOLE CAPSULE, EXTENDED RELEASE;ORAL ASPIRIN AND DIPYRIDAMOLE >A> AB SUN PHARMA GLOBAL 25MG;200MG A 208572 001 Aug 21, 2018 Aug NEWA

ATOVAQUONE SUSPENSION;ORAL ATOVAQUONE >A> AB LUPIN LTD 750MG/5ML A 209105 001 Sep 11, 2018 Aug NEWA

ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE TABLET;ORAL DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE >A> AA UPSHER-SMITH LABS 0.025MG;2.5MG A 210571 001 Aug 31, 2018 Aug NEWA

BAZEDOXIFENE ACETATE; ESTROGENS, CONJUGATED TABLET;ORAL DUAVEE >A> +! WYETH PHARMS EQ 20MG BASE;0.45MG N 022247 001 Oct 03, 2013 Aug CAHN >D> +! WYETH PHARMS PFIZER EQ 20MG BASE;0.45MG N 022247 001 Oct 03, 2013 Aug CAHN

BENZTROPINE MESYLATE TABLET;ORAL BENZTROPINE MESYLATE >A> @ CHARTWELL RX 1MG A 081265 002 Jan 23, 1992 Aug CMS1

BETAMETHASONE DIPROPIONATE LOTION, AUGMENTED;TOPICAL BETAMETHASONE DIPROPIONATE >D> AB TARO EQ 0.05% BASE A 077477 001 May 21, 2007 Aug CHRS >A> AB ! EQ 0.05% BASE A 077477 001 May 21, 2007 Aug CHRS >D> DIPROLENE >D> AB +! MERCK SHARP DOHME EQ 0.05% BASE N 019716 001 Aug 01, 1988 Aug DISC >A> + @ EQ 0.05% BASE N 019716 001 Aug 01, 1988 Aug DISC

BEXAROTENE CAPSULE;ORAL BEXAROTENE >A> AB AMNEAL PHARMS NY 75MG A 210105 001 Sep 04, 2018 Aug NEWA

BISOPROLOL FUMARATE TABLET;ORAL ZEBETA >D> @ TEVA WOMENS 5MG N 019982 002 Jul 31, 1992 Aug CRLD >A> + @ 5MG N 019982 002 Jul 31, 1992 Aug CRLD >D> @ 10MG N 019982 001 Jul 31, 1992 Aug CRLD >A> + @ 10MG N 019982 001 Jul 31, 1992 Aug CRLD

BUDESONIDE CAPSULE;ORAL BUDESONIDE >D> AB APPCO PHARMA LLC 3MG A 207367 001 Apr 07, 2017 Aug CAHN >A> AB RISING PHARMS 3MG A 207367 001 Apr 07, 2017 Aug CAHN

CAFFEINE; ERGOTAMINE TARTRATE SUPPOSITORY;RECTAL MIGERGOT >D> ! HORIZON PHARMA 100MG;2MG A 086557 001 Oct 04, 1983 Aug CAHN >A> ! HZNP 100MG;2MG A 086557 001 Oct 04, 1983 Aug CAHN

CALCIUM CHLORIDE; DEXTROSE; GLUTATHIONE DISULFIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE SOLUTION;IRRIGATION BSS PLUS >D> AT +! ALCON 0.154MG/ML;0.92MG/ML;0.184MG/ML N 018469 001 Oct 28, 1981 Aug CTEC ;0.2MG/ML;0.38MG/ML;2.1MG/ML;7. 14MG/ML;0.42MG/ML >A> +! 0.154MG/ML;0.92MG/ML;0.184MG/ML N 018469 001 Oct 28, 1981 Aug CTEC ;0.2MG/ML;0.38MG/ML;2.1MG/ML;7. 14MG/ML;0.42MG/ML >D> ENDOSOL EXTRA >D> AT +! AKORN 0.154MG/ML;0.92MG/ML;0.184MG/ML N 020079 001 Nov 27, 1991 Aug DISC ;0.2MG/ML;0.38MG/ML;2.1

Page 4 of 23 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

CALCIUM CHLORIDE; DEXTROSE; GLUTATHIONE DISULFIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE SOLUTION;IRRIGATION >D> ENDOSOL EXTRA MG/ML;7.14MG/ML;0.42MG/ML METHOTREXATE SODIUM >A> @ AKORN 0.154MG/ML;0.92MG/ML;0.184MG/ML N 020079 001 Feb 26, 1999 Aug DISC ;0.2MG/ML;0.38MG/ML;2.1MG/ML;7. 14MG/ML;0.42MG/ML

CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE >D> INJECTABLE;INJECTION >D> DEXTROSE 5% IN RINGER'S IN PLASTIC CONTAINER >D> B BRAUN 33MG/100ML;5GM/100ML;30MG/100ML N 020000 001 Apr 17, 1992 Aug DISC ;860MG/100ML >A> @ 33MG/100ML;5GM/100ML;30MG/100ML N 020000 001 Apr 17, 1992 Aug DISC ;860MG/100ML

CARISOPRODOL CAPSULE;ORAL SOMA >D> @ MYLAN SPECIALITY LP 250MG N 011792 003 Nov 04, 1959 Aug CRLD >A> + @ 250MG N 011792 003 Nov 04, 1959 Aug CRLD

CARMUSTINE INJECTABLE;INJECTION BICNU >D> +! EMCURE PHARMS LTD 100MG/VIAL N 017422 001 Mar 07, 1977 Aug CFTG >A> AP +! 100MG/VIAL N 017422 001 Mar 07, 1977 Aug CFTG >A> CARMUSTINE >A> AP NAVINTA LLC 100MG/VIAL A 210179 001 Sep 11, 2018 Aug NEWA

CEFEPIME HYDROCHLORIDE POWDER;INTRAVENOUS CEFEPIME HYDROCHLORIDE IN PLASTIC CONTAINER >A> SAMSON MEDCL EQ 100GM BASE A 209408 001 Aug 21, 2018 Aug NEWA

CHLORPHENIRAMINE POLISTIREX; CODEINE POLISTIREX SUSPENSION, EXTENDED RELEASE;ORAL CODEPREX >A> @ LANNETT CO INC EQ 4MG MALEATE/5ML;EQ 20MG N 021369 001 Jun 21, 2004 Aug CAHN BASE/5ML >D> @ UCB INC EQ 4MG MALEATE/5ML;EQ 20MG N 021369 001 Jun 21, 2004 Aug CAHN BASE/5ML

CHLORPROMAZINE HYDROCHLORIDE TABLET;ORAL CHLORPROMAZINE HYDROCHLORIDE >A> AB AMNEAL PHARMS CO 10MG A 209755 001 Sep 10, 2018 Aug NEWA >A> AB 25MG A 209755 002 Sep 10, 2018 Aug NEWA >A> AB 50MG A 209755 003 Sep 10, 2018 Aug NEWA >A> AB 100MG A 209755 004 Sep 10, 2018 Aug NEWA >A> AB 200MG A 209755 005 Sep 10, 2018 Aug NEWA >D> USL PHARMA 10MG A 083386 001 Jul 09, 1974 Aug CTEC >A> AB 10MG A 083386 001 Jul 09, 1974 Aug CTEC >D> ! 25MG A 084112 001 Jul 09, 1974 Aug CTEC >A> AB ! 25MG A 084112 001 Jul 09, 1974 Aug CTEC >D> 50MG A 084113 001 Jul 09, 1974 Aug CTEC >A> AB 50MG A 084113 001 Jul 09, 1974 Aug CTEC >D> ! 100MG A 084114 001 Jul 09, 1974 Aug CTEC >A> AB ! 100MG A 084114 001 Jul 09, 1974 Aug CTEC >D> 200MG A 084115 001 Jul 09, 1974 Aug CTEC >A> AB 200MG A 084115 001 Jul 09, 1974 Aug CTEC

CILOSTAZOL TABLET;ORAL CILOSTAZOL >D> @ FRONTIDA BIOPHARM 50MG A 077208 002 Mar 29, 2006 Aug CMFD >A> AB 50MG A 077208 002 Mar 29, 2006 Aug CMFD >D> @ 100MG A 077208 001 Mar 29, 2006 Aug CMFD >A> AB 100MG A 077208 001 Mar 29, 2006 Aug CMFD

Page 5 of 23 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

CLOBETASOL PROPIONATE OINTMENT;TOPICAL CLOBETASOL PROPIONATE >A> AB AMNEAL PHARMS LLC 0.05% A 210551 001 Aug 21, 2018 Aug NEWA

CONIVAPTAN HYDROCHLORIDE >A> INJECTABLE;INTRAVENOUS >A> VAPRISOL >A> @ CUMBERLAND PHARMS 20MG/4ML (5MG/ML) N 021697 001 Dec 29, 2005 Aug CDFR >A> VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER >A> +! CUMBERLAND PHARMS 20MG/100ML (0.2MG/ML) N 021697 002 Oct 08, 2008 Aug CDFR >D> INJECTABLE;IV (INFUSION) >D> VAPRISOL >D> @ CUMBERLAND PHARMS 20MG/4ML (5MG/ML) N 021697 001 Dec 29, 2005 Aug CDFR >D> VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER >D> +! CUMBERLAND PHARMS 20MG/100ML (0.2MG/ML) N 021697 002 Oct 08, 2008 Aug CDFR

CYCLOSPORINE >A> SOLUTION;OPHTHALMIC >A> CEQUA >A> +! SUN PHARMA GLOBAL 0.09% N 210913 001 Aug 14, 2018 Aug NEWA

CYTARABINE INJECTABLE, LIPOSOMAL;INJECTION >D> DEPOCYT >D> +! PACIRA PHARMS INC 10MG/ML N 021041 001 Apr 01, 1999 Aug DISC >A> + @ 10MG/ML N 021041 001 Apr 01, 1999 Aug DISC

DALFOPRISTIN; QUINUPRISTIN >A> INJECTABLE;INTRAVENOUS >A> SYNERCID >A> +! KING PHARMS 350MG/VIAL;150MG/VIAL N 050748 001 Sep 21, 1999 Aug CDFR >A> @ 420MG/VIAL;180MG/VIAL N 050748 002 Aug 24, 2000 Aug CDFR >D> INJECTABLE;IV (INFUSION) >D> SYNERCID >D> +! KING PHARMS 350MG/VIAL;150MG/VIAL N 050748 001 Sep 21, 1999 Aug CDFR >D> @ 420MG/VIAL;180MG/VIAL N 050748 002 Aug 24, 2000 Aug CDFR

DEXAMETHASONE SODIUM PHOSPHATE INJECTABLE;INJECTION DEXAMETHASONE SODIUM PHOSPHATE >A> AP AMNEAL PHARMS CO EQ 4MG PHOSPHATE/ML A 208689 001 Aug 22, 2018 Aug NEWA DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE >A> AP AMNEAL PHARMS CO EQ 10MG PHOSPHATE/ML A 208690 001 Aug 22, 2018 Aug NEWA

DEXMEDETOMIDINE HYDROCHLORIDE INJECTABLE;INJECTION >A> DEXMEDETOMIDINE HYDROCHLORIDE >A> AP BAXTER HLTHCARE CORP EQ 200MCG BASE/50ML (EQ 4MCG A 208532 001 Aug 21, 2018 Aug NEWA BASE/ML) >A> AP EQ 400MCG BASE/100ML (EQ 4MCG A 208532 002 Aug 21, 2018 Aug NEWA BASE/ML) PRECEDEX >D> +! HOSPIRA EQ 200MCG BASE/50ML (EQ 4MCG N 021038 002 Mar 13, 2013 Aug CFTG BASE/ML) >A> AP +! EQ 200MCG BASE/50ML (EQ 4MCG N 021038 002 Mar 13, 2013 Aug CFTG BASE/ML) >D> +! EQ 400MCG BASE/100ML (EQ 4MCG N 021038 003 Mar 13, 2013 Aug CFTG BASE/ML) >A> AP +! EQ 400MCG BASE/100ML (EQ 4MCG N 021038 003 Mar 13, 2013 Aug CFTG BASE/ML)

DICLOFENAC POTASSIUM CAPSULE;ORAL ZIPSOR >A> AB +! ASSERTIO 25MG N 022202 001 Jun 16, 2009 Aug CAHN >D> AB +! DEPOMED INC 25MG N 022202 001 Jun 16, 2009 Aug CAHN FOR SOLUTION;ORAL CAMBIA >A> AB +! ASSERTIO 50MG N 022165 001 Jun 17, 2009 Aug CAHN >D> AB +! DEPOMED INC 50MG N 022165 001 Jun 17, 2009 Aug CAHN

Page 6 of 23 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

DICLOFENAC SODIUM SOLUTION;TOPICAL PENNSAID >D> +! HORIZON PHARMA 2% N 204623 001 Jan 16, 2014 Aug CAHN >A> +! HZNP 2% N 204623 001 Jan 16, 2014 Aug CAHN

DILTIAZEM HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL DILTIAZEM HYDROCHLORIDE >A> AB3 TWI PHARMS 120MG A 205231 001 Aug 30, 2018 Aug NEWA >A> AB3 180MG A 205231 002 Aug 30, 2018 Aug NEWA >A> AB3 240MG A 205231 003 Aug 30, 2018 Aug NEWA >A> AB3 300MG A 205231 004 Aug 30, 2018 Aug NEWA >A> AB3 360MG A 205231 005 Aug 30, 2018 Aug NEWA

DIPHENHYDRAMINE HYDROCHLORIDE INJECTABLE;INJECTION DIPHENYDRAMINE HYDROCHLORIDE >A> AP MICRO LABS 50MG/ML A 205723 001 Aug 22, 2018 Aug NEWA

DOCETAXEL INJECTABLE;INJECTION DOCETAXEL >A> AP CIPLA LTD 20MG/2ML (10MG/ML) A 209634 001 Aug 24, 2018 Aug NEWA >A> AP 80MG/8ML (10MG/ML) A 209634 002 Aug 24, 2018 Aug NEWA >A> AP 160MG/16ML (10MG/ML) A 209634 003 Aug 24, 2018 Aug NEWA

DONEPEZIL HYDROCHLORIDE TABLET, ORALLY DISINTEGRATING;ORAL >D> ARICEPT ODT >D> AB + EISAI INC 5MG N 021720 001 Oct 18, 2004 Aug DISC >A> + @ 5MG N 021720 001 Oct 18, 2004 Aug DISC >D> AB +! 10MG N 021720 002 Oct 18, 2004 Aug DISC >A> + @ 10MG N 021720 002 Oct 18, 2004 Aug DISC DONEPEZIL HYDROCHLORIDE >D> AB BARR 5MG A 078388 002 Nov 26, 2010 Aug DISC >A> @ 5MG A 078388 002 Nov 26, 2010 Aug DISC >D> AB 10MG A 078388 001 Nov 26, 2010 Aug DISC >A> @ 10MG A 078388 001 Nov 26, 2010 Aug DISC >D> AB SANDOZ 10MG A 091198 002 May 10, 2011 Aug CHRS >A> AB ! 10MG A 091198 002 May 10, 2011 Aug CHRS >D> AB ZYDUS PHARMS USA INC 5MG A 090175 001 May 10, 2011 Aug DISC >A> @ 5MG A 090175 001 May 10, 2011 Aug DISC >D> AB 10MG A 090175 002 May 10, 2011 Aug DISC >A> @ 10MG A 090175 002 May 10, 2011 Aug DISC TABLET;ORAL DONEPEZIL HYDROCHLORIDE >A> AB HISUN PHARM HANGZHOU 23MG A 202410 001 Mar 24, 2017 Aug CAHN >D> AB ZHEJIANG HISUN PHARM 23MG A 202410 001 Mar 24, 2017 Aug CAHN

DOPAMINE HYDROCHLORIDE INJECTABLE;INJECTION DOPAMINE HYDROCHLORIDE >D> ! LUITPOLD 160MG/ML A 070826 001 Feb 11, 1987 Aug DISC >A> @ 160MG/ML A 070826 001 Feb 11, 1987 Aug DISC

>A> DORAVIRINE >A> TABLET;ORAL >A> PIFELTRO >A> +! MSD MERCK CO 100MG N 210806 001 Aug 30, 2018 Aug NEWA

>A> DORAVIRINE; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE >A> TABLET;ORAL >A> DELSTRIGO >A> +! MSD MERCK CO 100MG;300MG;300MG N 210807 001 Aug 30, 2018 Aug NEWA

Page 7 of 23 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

DOXERCALCIFEROL CAPSULE;ORAL HECTOROL >D> AB + GENZYME CORP 0.5MCG N 020862 002 Apr 23, 2004 Aug CAHN >D> AB + 1MCG N 020862 003 Jul 13, 2009 Aug CAHN >D> AB +! 2.5MCG N 020862 001 Jun 09, 1999 Aug CAHN >A> AB + SANOFI 0.5MCG N 020862 002 Apr 23, 2004 Aug CAHN >A> AB + 1MCG N 020862 003 Jul 13, 2009 Aug CAHN >A> AB +! 2.5MCG N 020862 001 Jun 09, 1999 Aug CAHN INJECTABLE;INJECTION HECTOROL >D> AP + GENZYME CORP 2MCG/ML (2MCG/ML) N 021027 002 Apr 06, 2000 Aug CAHN >D> AP +! 4MCG/2ML (2MCG/ML) N 021027 001 Apr 06, 2000 Aug CAHN >A> AP + SANOFI 2MCG/ML (2MCG/ML) N 021027 002 Apr 06, 2000 Aug CAHN >A> AP +! 4MCG/2ML (2MCG/ML) N 021027 001 Apr 06, 2000 Aug CAHN

EFAVIRENZ TABLET;ORAL EFAVIRENZ >A> AB AUROBINDO PHARMA LTD 600MG A 205322 001 Aug 30, 2018 Aug NEWA

EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET;ORAL ATRIPLA >D> +! GILEAD SCIENCES 600MG;200MG;300MG N 021937 001 Jul 12, 2006 Aug CFTG >A> AB +! 600MG;200MG;300MG N 021937 001 Jul 12, 2006 Aug CFTG EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE >A> AB AUROBINDO PHARMA LTD 600MG;200MG;300MG A 203041 001 Sep 04, 2018 Aug NEWA

EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE TABLET;ORAL EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE >A> AUROBINDO PHARMA LTD 600MG;300MG;300MG N 022343 001 Aug 15, 2018 Aug NEWA

EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET;ORAL >A> EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE >A> AB AMNEAL PHARMS CO 100MG;150MG A 209721 001 Aug 22, 2018 Aug NEWA >A> AB 133MG;200MG A 209721 002 Aug 22, 2018 Aug NEWA >A> AB 167MG;250MG A 209721 003 Aug 22, 2018 Aug NEWA >A> AB 200MG;300MG A 209721 004 Aug 22, 2018 Aug NEWA TRUVADA >D> + GILEAD 100MG;150MG N 021752 002 Mar 10, 2016 Aug CFTG >A> AB + 100MG;150MG N 021752 002 Mar 10, 2016 Aug CFTG >D> + 133MG;200MG N 021752 003 Mar 10, 2016 Aug CFTG >A> AB + 133MG;200MG N 021752 003 Mar 10, 2016 Aug CFTG >D> + 167MG;250MG N 021752 004 Mar 10, 2016 Aug CFTG >A> AB + 167MG;250MG N 021752 004 Mar 10, 2016 Aug CFTG

EPINEPHRINE INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS ADRENACLICK >A> BX +! IMPAX EQ 0.15MG/DELIVERY N 020800 003 Nov 25, 2009 Aug CAHN >A> BX +! EQ 0.3MG/DELIVERY N 020800 004 Nov 25, 2009 Aug CAHN >D> BX +! IMPAX LABS INC EQ 0.15MG/DELIVERY N 020800 003 Nov 25, 2009 Aug CAHN >D> BX +! EQ 0.3MG/DELIVERY N 020800 004 Nov 25, 2009 Aug CAHN TWINJECT 0.15 >A> @ IMPAX EQ 0.15MG/DELIVERY N 020800 002 May 28, 2004 Aug CAHN >D> @ IMPAX LABS INC EQ 0.15MG/DELIVERY N 020800 002 May 28, 2004 Aug CAHN TWINJECT 0.3 >A> @ IMPAX EQ 0.3MG/DELIVERY N 020800 001 May 30, 2003 Aug CAHN >D> @ IMPAX LABS INC EQ 0.3MG/DELIVERY N 020800 001 May 30, 2003 Aug CAHN

>A> ERAVACYCLINE DIHYDROCHLORIDE >A> POWDER;INTRAVENOUS >A> XERAVA >A> +! TETRAPHASE PHARMS EQ 50MG BASE/VIAL N 211109 001 Aug 27, 2018 Aug NEWA

Page 8 of 23 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED REL PELLETS;ORAL ESOMEPRAZOLE MAGNESIUM >A> AB HEC PHARM EQ 20MG BASE A 207265 002 May 18, 2018 Aug CAHN >A> AB EQ 40MG BASE A 207265 001 May 18, 2018 Aug CAHN >D> AB HEC PHARM CO LTD EQ 20MG BASE A 207265 002 May 18, 2018 Aug CAHN >D> AB EQ 40MG BASE A 207265 001 May 18, 2018 Aug CAHN

ESOMEPRAZOLE MAGNESIUM; NAPROXEN TABLET, DELAYED RELEASE;ORAL VIMOVO >A> AB + HORIZON EQ 20MG BASE;375MG N 022511 002 Apr 30, 2010 Aug CAHN >A> + EQ 20MG BASE;375MG N 022511 002 Apr 30, 2010 Aug CTEC >A> AB +! EQ 20MG BASE;500MG N 022511 001 Apr 30, 2010 Aug CAHN >A> +! EQ 20MG BASE;500MG N 022511 001 Apr 30, 2010 Aug CTEC >D> AB + HORIZON PHARMA USA EQ 20MG BASE;375MG N 022511 002 Apr 30, 2010 Aug CAHN >D> AB +! EQ 20MG BASE;500MG N 022511 001 Apr 30, 2010 Aug CAHN

ETHINYL ESTRADIOL; NORETHINDRONE TABLET;ORAL-28 BALZIVA-28 >D> AB BARR 0.035MG;0.4MG A 076238 001 Apr 22, 2004 Aug CHRS >A> AB ! 0.035MG;0.4MG A 076238 001 Apr 22, 2004 Aug CHRS NORETHINDRONE AND ETHINYL ESTRADIOL >D> AB ! MYLAN LABS LTD 0.035MG;0.4MG A 200897 001 May 11, 2015 Aug DISC >A> @ 0.035MG;0.4MG A 200897 001 May 11, 2015 Aug DISC

>A> ETHINYL ESTRADIOL; SEGESTERONE ACETATE >A> RING;VAGINAL >A> ANNOVERA >A> +! POPULATION COUNCIL 0.013MG/24HR;0.15MG/24HR N 209627 001 Aug 10, 2018 Aug NEWA

FAMOTIDINE; IBUPROFEN TABLET;ORAL DUEXIS >A> +! HORIZON 26.6MG;800MG N 022519 001 Apr 23, 2011 Aug CAHN >D> +! HORIZON PHARMA 26.6MG;800MG N 022519 001 Apr 23, 2011 Aug CAHN

FENOFIBRATE CAPSULE;ORAL FENOFIBRATE (MICRONIZED) >A> AB AJANTA PHARMA LTD 67MG A 210705 001 Sep 10, 2018 Aug NEWA >A> AB 134MG A 210705 002 Sep 10, 2018 Aug NEWA >A> AB 200MG A 210705 003 Sep 10, 2018 Aug NEWA TABLET;ORAL FENOFIBRATE >A> AB GRAVITI PHARMS 54MG A 210606 001 Aug 17, 2018 Aug NEWA >A> AB 160MG A 210606 002 Aug 17, 2018 Aug NEWA >A> AB PRINSTON INC 48MG A 211080 001 Aug 28, 2018 Aug NEWA >A> AB 145MG A 211080 002 Aug 28, 2018 Aug NEWA

FEXOFENADINE HYDROCHLORIDE >D> SUSPENSION;ORAL >D> FEXOFENADINE HYDROCHLORIDE >D> ! ACTAVIS MID ATLANTIC 30MG/5ML A 201311 001 Jul 25, 2012 Aug DISC >A> @ 30MG/5ML A 201311 001 Jul 25, 2012 Aug DISC

FISH OIL; MEDIUM CHAIN TRIGLYCERIDES; OLIVE OIL; SOYBEAN OIL EMULSION;INTRAVENOUS SMOFLIPID 20% >A> +! FRESENIUS KABI USA 3GM/100ML;6GM/100ML;5GM/100ML;6 N 207648 004 Aug 10, 2018 Aug NEWA GM/100ML (1000ML)

FLUOCINONIDE CREAM;TOPICAL FLUOCINONIDE >A> AB1 AMNEAL PHARMS LLC 0.05% A 210554 001 Aug 21, 2018 Aug NEWA

Page 9 of 23 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

FOSFOMYCIN TROMETHAMINE >A> FOR SOLUTION;ORAL >A> MONUROL >A> +! ZAMBON SPA EQ 3GM BASE/PACKET N 050717 001 Dec 19, 1996 Aug CDFR >D> FOR SUSPENSION;ORAL >D> MONUROL >D> +! ZAMBON SPA EQ 3GM BASE/PACKET N 050717 001 Dec 19, 1996 Aug CDFR

GABAPENTIN TABLET;ORAL GABAPENTIN >A> AB LUPIN LTD 600MG A 209306 001 Aug 24, 2018 Aug NEWA >A> AB 800MG A 209306 002 Aug 24, 2018 Aug NEWA GRALISE >A> BX +! ASSERTIO 300MG N 022544 001 Jan 28, 2011 Aug CAHN >A> BX +! 600MG N 022544 002 Jan 28, 2011 Aug CAHN >D> BX +! DEPOMED INC 300MG N 022544 001 Jan 28, 2011 Aug CAHN >D> BX +! 600MG N 022544 002 Jan 28, 2011 Aug CAHN

GADOVERSETAMIDE INJECTABLE;INJECTION OPTIMARK >D> +! LIEBEL-FLARSHEIM 1654.5MG/5ML (330.9MG/ML) N 020937 001 Dec 08, 1999 Aug DISC >A> + @ 1654.5MG/5ML (330.9MG/ML) N 020937 001 Dec 08, 1999 Aug DISC >D> +! 3309MG/10ML (330.9MG/ML) N 020937 002 Dec 08, 1999 Aug DISC >A> + @ 3309MG/10ML (330.9MG/ML) N 020937 002 Dec 08, 1999 Aug DISC >D> +! 4963.5MG/15ML (330.9MG/ML) N 020937 003 Dec 08, 1999 Aug DISC >A> + @ 4963.5MG/15ML (330.9MG/ML) N 020937 003 Dec 08, 1999 Aug DISC >D> +! 6618MG/20ML (330.9MG/ML) N 020937 004 Dec 08, 1999 Aug DISC >A> + @ 6618MG/20ML (330.9MG/ML) N 020937 004 Dec 08, 1999 Aug DISC >D> +! 16.545GM/50ML (330.9MG/ML) N 020975 001 Dec 08, 1999 Aug DISC >A> + @ 16.545GM/50ML (330.9MG/ML) N 020975 001 Dec 08, 1999 Aug DISC >D> OPTIMARK IN PLASTIC CONTAINER >D> +! LIEBEL-FLARSHEIM 3309MG/10ML (330.9MG/ML) N 020976 002 Dec 08, 1999 Aug DISC >A> + @ 3309MG/10ML (330.9MG/ML) N 020976 002 Dec 08, 1999 Aug DISC >D> +! 4963.5MG/15ML (330.9MG/ML) N 020976 003 Dec 08, 1999 Aug DISC >A> + @ 4963.5MG/15ML (330.9MG/ML) N 020976 003 Dec 08, 1999 Aug DISC >D> +! 6618MG/20ML (330.9MG/ML) N 020976 004 Dec 08, 1999 Aug DISC >A> + @ 6618MG/20ML (330.9MG/ML) N 020976 004 Dec 08, 1999 Aug DISC >D> +! 9927MG/30ML (330.9MG/ML) N 020976 001 Dec 08, 1999 Aug DISC >A> + @ 9927MG/30ML (330.9MG/ML) N 020976 001 Dec 08, 1999 Aug DISC

GATIFLOXACIN SOLUTION/DROPS;OPHTHALMIC GATIFLOXACIN >D> AT MICRO LABS 0.5% A 206446 001 Jun 08, 2018 Aug CAHN >A> AT MYLAN PHARMS INC 0.5% A 206446 001 Jun 08, 2018 Aug CAHN

GEMCITABINE HYDROCHLORIDE SOLUTION;INTRAVENOUS INFUGEM >D> +! SUN PHARM INDS INC EQ 1200MG BASE/120ML (EQ 10MG N 208313 001 Jul 16, 2018 Aug CAHN BASE/ML) >D> +! EQ 1300MG BASE/130ML (EQ 10MG N 208313 002 Jul 16, 2018 Aug CAHN BASE/ML) >D> +! EQ 1400MG BASE/140ML (EQ 10MG N 208313 003 Jul 16, 2018 Aug CAHN BASE/ML) >D> +! EQ 1500MG BASE/150ML (EQ 10MG N 208313 004 Jul 16, 2018 Aug CAHN BASE/ML) >D> +! EQ 1600MG BASE/160ML (EQ 10MG N 208313 005 Jul 16, 2018 Aug CAHN BASE/ML) >D> +! EQ 1700MG BASE/170ML (EQ 10MG N 208313 006 Jul 16, 2018 Aug CAHN BASE/ML) >D> +! EQ 1800MG BASE/180ML (EQ 10MG N 208313 007 Jul 16, 2018 Aug CAHN BASE/ML) >D> +! EQ 1900MG BASE/190ML (EQ 10MG N 208313 008 Jul 16, 2018 Aug CAHN BASE/ML) >D> +! EQ 2000MG BASE/200ML (EQ 10MG N 208313 009 Jul 16, 2018 Aug CAHN BASE/ML) >D> +! EQ 2200MG BASE/220ML (EQ 10MG N 208313 010 Jul 16, 2018 Aug CAHN BASE/ML) >A> +! SUN PHARM INDS LTD EQ 1200MG BASE/120ML (EQ 10MG N 208313 001 Jul 16, 2018 Aug CAHN BASE/ML)

Page 10 of 23 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

GEMCITABINE HYDROCHLORIDE SOLUTION;INTRAVENOUS INFUGEM >A> +! EQ 1300MG BASE/130ML (EQ 10MG N 208313 002 Jul 16, 2018 Aug CAHN BASE/ML) >A> +! EQ 1400MG BASE/140ML (EQ 10MG N 208313 003 Jul 16, 2018 Aug CAHN BASE/ML) >A> +! EQ 1500MG BASE/150ML (EQ 10MG N 208313 004 Jul 16, 2018 Aug CAHN BASE/ML) >A> +! EQ 1600MG BASE/160ML (EQ 10MG N 208313 005 Jul 16, 2018 Aug CAHN BASE/ML) >A> +! EQ 1700MG BASE/170ML (EQ 10MG N 208313 006 Jul 16, 2018 Aug CAHN BASE/ML) >A> +! EQ 1800MG BASE/180ML (EQ 10MG N 208313 007 Jul 16, 2018 Aug CAHN BASE/ML) >A> +! EQ 1900MG BASE/190ML (EQ 10MG N 208313 008 Jul 16, 2018 Aug CAHN BASE/ML) >A> +! EQ 2000MG BASE/200ML (EQ 10MG N 208313 009 Jul 16, 2018 Aug CAHN BASE/ML) >A> +! EQ 2200MG BASE/220ML (EQ 10MG N 208313 010 Jul 16, 2018 Aug CAHN BASE/ML)

GEMFIBROZIL TABLET;ORAL GEMFIBROZIL >A> AB ZYDUS PHARMS USA INC 600MG A 204189 001 Aug 28, 2018 Aug NEWA

GUAIFENESIN; HYDROCODONE BITARTRATE >D> SOLUTION;ORAL >D> FLOWTUSS >D> BKK PHARMS 200MG/5ML;2.5MG/5ML N 022424 001 May 14, 2015 Aug DISC >A> @ 200MG/5ML;2.5MG/5ML N 022424 001 May 14, 2015 Aug DISC

>D> GUAIFENESIN; HYDROCODONE BITARTRATE; PSEUDOEPHEDRINE HYDROCHLORIDE >D> SOLUTION;ORAL >D> HYCOFENIX >D> +! BKK PHARMS 200MG/5ML;2.5MG/5ML;30MG/5ML N 022279 001 May 14, 2015 Aug DISC >A> + @ 200MG/5ML;2.5MG/5ML;30MG/5ML N 022279 001 May 14, 2015 Aug DISC

HEPARIN SODIUM INJECTABLE;INJECTION HEPARIN SODIUM >D> @ WEST-WARD PHARMS INT 1,000 UNITS/ML N 017007 001 May 28, 1974 Aug CRLD >A> + @ 1,000 UNITS/ML N 017007 001 May 28, 1974 Aug CRLD >D> @ 2,500 UNITS/ML N 017007 007 Feb 02, 1978 Aug CRLD >A> + @ 2,500 UNITS/ML N 017007 007 Feb 02, 1978 Aug CRLD >D> @ 5,000 UNITS/ML N 017007 002 May 28, 1974 Aug CRLD >A> + @ 5,000 UNITS/ML N 017007 002 May 28, 1974 Aug CRLD >D> @ 5,000 UNITS/0.5ML N 017007 010 Feb 08, 1978 Aug CRLD >A> + @ 5,000 UNITS/0.5ML N 017007 010 Feb 08, 1978 Aug CRLD >D> @ 7,500 UNITS/ML N 017007 003 May 28, 1974 Aug CRLD >A> + @ 7,500 UNITS/ML N 017007 003 May 28, 1974 Aug CRLD >D> @ 10,000 UNITS/ML N 017007 004 May 28, 1974 Aug CRLD >A> + @ 10,000 UNITS/ML N 017007 004 May 28, 1974 Aug CRLD >D> @ 15,000 UNITS/ML N 017007 005 May 28, 1974 Aug CRLD >A> + @ 15,000 UNITS/ML N 017007 005 May 28, 1974 Aug CRLD >D> @ 20,000 UNITS/ML N 017007 006 May 28, 1974 Aug CRLD >A> + @ 20,000 UNITS/ML N 017007 006 May 28, 1974 Aug CRLD

HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE SYRUP;ORAL HYCODAN >D> + @ ENDO PHARMS 1.5MG/5ML;5MG/5ML N 005213 002 Jul 26, 1988 Aug CAHN >A> + @ GENUS LIFESCIENCES 1.5MG/5ML;5MG/5ML N 005213 002 Jul 26, 1988 Aug CAHN TABLET;ORAL HYCODAN >D> + @ ENDO PHARMS 1.5MG;5MG N 005213 001 Jul 26, 1988 Aug CAHN >A> + @ GENUS LIFESCIENCES 1.5MG;5MG N 005213 001 Jul 26, 1988 Aug CAHN

Page 11 of 23 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

HYDROCHLOROTHIAZIDE; IRBESARTAN TABLET;ORAL IRBESARTAN AND HYDROCHLOROTHIAZIDE >D> AB ATLAS PHARMS LLC 12.5MG;150MG A 203036 001 Jan 15, 2016 Aug DISC >A> @ 12.5MG;150MG A 203036 001 Jan 15, 2016 Aug DISC >D> AB 12.5MG;300MG A 203036 002 Jan 15, 2016 Aug DISC >A> @ 12.5MG;300MG A 203036 002 Jan 15, 2016 Aug DISC >D> AB 25MG;300MG A 203036 003 Jan 15, 2016 Aug DISC >A> @ 25MG;300MG A 203036 003 Jan 15, 2016 Aug DISC >D> AB HISUN PHARM 12.5MG;150MG A 207896 001 Oct 14, 2016 Aug CAHN >D> AB 12.5MG;300MG A 207896 002 Oct 14, 2016 Aug CAHN >A> AB HISUN PHARM HANGZHOU 12.5MG;150MG A 207896 001 Oct 14, 2016 Aug CAHN >A> AB 12.5MG;300MG A 207896 002 Oct 14, 2016 Aug CAHN

HYDROCHLOROTHIAZIDE; VALSARTAN TABLET;ORAL VALSARTAN AND HYDROCHLOROTHIAZIDE >D> AB WATSON LABS TEVA 12.5MG;80MG A 091519 001 Mar 21, 2013 Aug DISC >A> @ 12.5MG;80MG A 091519 001 Mar 21, 2013 Aug DISC >D> AB 12.5MG;160MG A 091519 002 Mar 21, 2013 Aug DISC >A> @ 12.5MG;160MG A 091519 002 Mar 21, 2013 Aug DISC >D> AB 12.5MG;320MG A 091519 003 Mar 21, 2013 Aug DISC >A> @ 12.5MG;320MG A 091519 003 Mar 21, 2013 Aug DISC >D> AB 25MG;160MG A 091519 004 Mar 21, 2013 Aug DISC >A> @ 25MG;160MG A 091519 004 Mar 21, 2013 Aug DISC >D> AB 25MG;320MG A 091519 005 Mar 21, 2013 Aug DISC >A> @ 25MG;320MG A 091519 005 Mar 21, 2013 Aug DISC

HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE AEROSOL, METERED;TOPICAL HYDROCORTISONE ACETATE 1% AND PRAMOXINE HYDROCHLORIDE 1% >A> @ GENUS LIFESCIENCES 1%;1% A 089440 001 May 17, 1988 Aug CAHN >D> @ VINTAGE PHARMS 1%;1% A 089440 001 May 17, 1988 Aug CAHN

HYDROCORTISONE BUTYRATE LOTION;TOPICAL HYDROCORTISONE BUTYRATE >A> AB LUPIN LTD 0.1% A 210209 001 Aug 17, 2018 Aug NEWA

HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE SOLUTION/DROPS;OTIC >D> CORTISPORIN >D> AT +! MONARCH PHARMS 1%;EQ 3.5MG BASE/ML;10,000 N 050479 001 Nov 15, 1975 Aug DISC UNITS/ML >A> + @ 1%;EQ 3.5MG BASE/ML;10,000 N 050479 001 Nov 15, 1975 Aug DISC UNITS/ML NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE >D> AT AMRING PHARMS 1%;EQ 3.5MG BASE/ML;10,000 A 065216 001 Oct 31, 2005 Aug DISC UNITS/ML >A> @ 1%;EQ 3.5MG BASE/ML;10,000 A 065216 001 Oct 31, 2005 Aug DISC UNITS/ML >D> AT BAUSCH AND LOMB 1%;EQ 3.5MG BASE/ML;10,000 A 064053 001 Dec 29, 1995 Aug CHRS UNITS/ML >A> AT ! 1%;EQ 3.5MG BASE/ML;10,000 A 064053 001 Dec 29, 1995 Aug CHRS UNITS/ML

HYDROMORPHONE HYDROCHLORIDE INJECTABLE;INJECTION DILAUDID >D> AP +! FRESENIUS KABI USA 4MG/ML N 019034 005 Apr 30, 2009 Aug DISC >A> + @ 4MG/ML N 019034 005 Apr 30, 2009 Aug DISC DILAUDID-HP >D> AP +! FRESENIUS KABI USA 10MG/ML N 019034 001 Jan 11, 1984 Aug DISC >A> + @ 10MG/ML N 019034 001 Jan 11, 1984 Aug DISC

HYDROXYZINE HYDROCHLORIDE INJECTABLE;INJECTION HYDROXYZINE HYDROCHLORIDE >D> AP ! FRESENIUS KABI USA 25MG/ML A 087329 001 Aug 11, 1981 Aug DISC >A> @ 25MG/ML A 087329 001 Aug 11, 1981 Aug DISC >D> AP ! 50MG/ML A 087329 002 Aug 11, 1981 Aug DISC >A> @ 50MG/ML A 087329 002 Aug 11, 1981 Aug DISC

Page 12 of 23 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

HYDROXYZINE HYDROCHLORIDE INJECTABLE;INJECTION HYDROXYZINE HYDROCHLORIDE >D> AP LUITPOLD 25MG/ML A 087408 001 Aug 27, 1981 Aug CTEC >A> 25MG/ML A 087408 001 Aug 27, 1981 Aug CTEC >A> ! 25MG/ML A 087408 001 Aug 27, 1981 Aug CHRS >D> AP 50MG/ML A 087408 002 Aug 27, 1981 Aug CTEC >A> 50MG/ML A 087408 002 Aug 27, 1981 Aug CTEC >A> ! 50MG/ML A 087408 002 Aug 27, 1981 Aug CHRS

IBUPROFEN TABLET;ORAL IBUPROFEN >A> AB HEC PHARM 400MG A 204062 001 Sep 10, 2018 Aug NEWA >A> AB 600MG A 204062 002 Sep 10, 2018 Aug NEWA >A> AB 800MG A 204062 003 Sep 10, 2018 Aug NEWA

IOTHALAMATE MEGLUMINE INJECTABLE;INJECTION >D> CONRAY 30 >D> +! LIEBEL-FLARSHEIM 30% N 016983 001 Aug 06, 1971 Aug DISC >A> + @ 30% N 016983 001 Aug 06, 1971 Aug DISC

IRBESARTAN TABLET;ORAL IRBESARTAN >D> AB DR REDDYS LABS LTD 75MG A 203161 001 Sep 27, 2012 Aug CAHN >D> AB 150MG A 203161 002 Sep 27, 2012 Aug CAHN >D> AB 300MG A 203161 003 Sep 27, 2012 Aug CAHN >D> AB HISUN PHARM 75MG A 206194 001 Jun 14, 2016 Aug CAHN >D> AB 150MG A 206194 002 Jun 14, 2016 Aug CAHN >D> AB 300MG A 206194 003 Jun 14, 2016 Aug CAHN >A> AB HISUN PHARM HANGZHOU 75MG A 206194 001 Jun 14, 2016 Aug CAHN >A> AB 150MG A 206194 002 Jun 14, 2016 Aug CAHN >A> AB 300MG A 206194 003 Jun 14, 2016 Aug CAHN >A> AB NEOPHARMA 75MG A 203161 001 Sep 27, 2012 Aug CAHN >A> AB 150MG A 203161 002 Sep 27, 2012 Aug CAHN >A> AB 300MG A 203161 003 Sep 27, 2012 Aug CAHN

IRINOTECAN HYDROCHLORIDE INJECTABLE;INJECTION IRINOTECAN HYDROCHLORIDE >D> AP DR REDDYS LABS LTD 40MG/2ML (20MG/ML) A 078953 001 Apr 15, 2010 Aug CAHN >D> AP 100MG/5ML (20MG/ML) A 078953 002 Apr 15, 2010 Aug CAHN >A> AP NEOPHARMA 40MG/2ML (20MG/ML) A 078953 001 Apr 15, 2010 Aug CAHN >A> AP 100MG/5ML (20MG/ML) A 078953 002 Apr 15, 2010 Aug CAHN

ISOSORBIDE MONONITRATE TABLET, EXTENDED RELEASE;ORAL ISOSORBIDE MONONITRATE >A> AB DEXCEL LTD 120MG A 210822 001 Aug 29, 2018 Aug NEWA

ITRACONAZOLE CAPSULE;ORAL ITRACONAZOLE >A> AB TORRENT PHARMS LTD 100MG A 209460 001 Aug 24, 2018 Aug NEWA SOLUTION;ORAL ITRACONAZOLE >D> @ AMNEAL PHARMS 10MG/ML A 205573 001 Oct 30, 2015 Aug CMFD >A> AA 10MG/ML A 205573 001 Oct 30, 2015 Aug CMFD SPORANOX >D> +! JANSSEN PHARMS 10MG/ML N 020657 001 Feb 21, 1997 Aug CTEC >A> AA +! 10MG/ML N 020657 001 Feb 21, 1997 Aug CTEC

IVACAFTOR; LUMACAFTOR >A> GRANULE;ORAL >A> ORKAMBI >A> + VERTEX PHARMS INC 125MG/PACKET;100MG/PACKET N 211358 001 Aug 07, 2018 Aug NEWA >A> +! 188MG/PACKET;150MG/PACKET N 211358 002 Aug 07, 2018 Aug NEWA

Page 13 of 23 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

KETOROLAC TROMETHAMINE TABLET;ORAL KETOROLAC TROMETHAMINE >A> AB CYCLE PHARMS LTD 10MG A 210616 001 Aug 16, 2018 Aug NEWA

LABETALOL HYDROCHLORIDE INJECTABLE;INJECTION LABETALOL HYDROCHLORIDE >D> AP AKORN INC 5MG/ML A 075524 001 Nov 29, 1999 Aug DISC >A> @ 5MG/ML A 075524 001 Nov 29, 1999 Aug DISC TABLET;ORAL LABETALOL HYDROCHLORIDE >D> AB APPCO PHARMA LLC 100MG A 209603 001 Jun 20, 2018 Aug CAHN >D> AB 200MG A 209603 002 Jun 20, 2018 Aug CAHN >D> AB 300MG A 209603 003 Jun 20, 2018 Aug CAHN >A> AB TWI PHARMS 100MG A 209603 001 Jun 20, 2018 Aug CAHN >A> AB 200MG A 209603 002 Jun 20, 2018 Aug CAHN >A> AB 300MG A 209603 003 Jun 20, 2018 Aug CAHN

>A> LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE >A> TABLET;ORAL >A> LAMIVUDINE, NEVIRAPINE AND ZIDOVUDINE >A> + @ MICRO LABS 150MG;200MG;300MG N 205626 001 Aug 13, 2018 Aug NEWA

LAMIVUDINE; ZIDOVUDINE TABLET;ORAL LAMIVUDINE AND ZIDOVUDINE >A> AB CIPLA LTD 150MG;300MG A 077411 001 Sep 07, 2018 Aug NEWA >A> AB MACLEODS PHARMS LTD 150MG;300MG A 090679 001 Aug 29, 2018 Aug NEWA

LEUPROLIDE ACETATE FOR SUSPENSION;INTRAMUSCULAR >A> LUTRATE DEPOT KIT >A> +! GP-PHARM SA 22.5MG/VIAL N 205054 001 Aug 28, 2018 Aug NEWA

LEVOCETIRIZINE DIHYDROCHLORIDE TABLET;ORAL LEVOCETIRIZINE DIHYDROCHLORIDE >D> AB ALLIED PHARMA INC 5MG A 204323 001 Dec 20, 2016 Aug CAHN >A> AB NEOPHARMA 5MG A 204323 001 Dec 20, 2016 Aug CAHN

LIDOCAINE HYDROCHLORIDE JELLY;TOPICAL LIDOCAINE HYDROCHLORIDE >D> AT WATSON LABS INC 2% A 040837 001 Mar 23, 2011 Aug DISC >A> @ 2% A 040837 001 Mar 23, 2011 Aug DISC

LOTEPREDNOL ETABONATE SUSPENSION/DROPS;OPHTHALMIC >A> INVELTYS >A> +! KALA PHARMS INC 1% N 210565 001 Aug 22, 2018 Aug NEWA

MAGNESIUM SULFATE INJECTABLE;INJECTION MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER >A> AP MYLAN LABS LTD 1GM/100ML A 209932 001 Sep 10, 2018 Aug NEWA

MECHLORETHAMINE HYDROCHLORIDE GEL;TOPICAL VALCHLOR >D> +! ACTELION PHARMS LTD EQ 0.016% BASE N 202317 001 Aug 23, 2013 Aug CAHN >A> +! HELSINN EQ 0.016% BASE N 202317 001 Aug 23, 2013 Aug CAHN

METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL METFORMIN HYDROCHLORIDE >A> AB1 PRINSTON INC 500MG A 208880 001 Sep 10, 2018 Aug NEWA >A> AB 750MG A 208880 002 Sep 10, 2018 Aug NEWA TABLET;ORAL METFORMIN HYDROCHLORIDE >A> AB LAURUS LABS LTD 500MG A 209882 001 Aug 27, 2018 Aug NEWA

Page 14 of 23 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

METFORMIN HYDROCHLORIDE TABLET;ORAL METFORMIN HYDROCHLORIDE >A> AB 850MG A 209882 002 Aug 27, 2018 Aug NEWA >A> AB 1GM A 209882 003 Aug 27, 2018 Aug NEWA

METHOTREXATE SODIUM INJECTABLE;INJECTION METHOTREXATE SODIUM >D> AP ! FRESENIUS KABI USA EQ 250MG BASE/10ML (EQ 25MG A 040263 002 Feb 26, 1999 Aug DISC BASE/ML) >A> @ EQ 250MG BASE/10ML (EQ 25MG A 040263 002 Feb 26, 1999 Aug DISC BASE/ML)

METHYLERGONOVINE MALEATE TABLET;ORAL METHYLERGONOVINE MALEATE >A> AB AMNEAL PHARMS 0.2MG A 211483 001 Sep 10, 2018 Aug NEWA

METHYLPHENIDATE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL >A> JORNAY PM >A> + IRONSHORE PHARMS 20MG N 209311 001 Aug 08, 2018 Aug NEWA >A> + 40MG N 209311 002 Aug 08, 2018 Aug NEWA >A> + 60MG N 209311 003 Aug 08, 2018 Aug NEWA >A> + 80MG N 209311 004 Aug 08, 2018 Aug NEWA >A> + 100MG N 209311 005 Aug 08, 2018 Aug NEWA TABLET, EXTENDED RELEASE, CHEWABLE;ORAL QUILLICHEW ER >A> + NEXTWAVE PHARMS 20MG N 207960 001 Dec 04, 2015 Aug CAHN >A> + 30MG N 207960 002 Dec 04, 2015 Aug CAHN >A> +! 40MG N 207960 003 Dec 04, 2015 Aug CAHN >D> + PFIZER INC 20MG N 207960 001 Dec 04, 2015 Aug CAHN >D> + 30MG N 207960 002 Dec 04, 2015 Aug CAHN >D> +! 40MG N 207960 003 Dec 04, 2015 Aug CAHN TABLET, EXTENDED RELEASE;ORAL METHYLIN ER >D> AB SPECGX LLC 20MG A 075629 002 May 09, 2000 Aug CHRS >A> AB ! 20MG A 075629 002 May 09, 2000 Aug CHRS >D> RITALIN-SR >D> AB + NOVARTIS 20MG N 018029 001 Mar 30, 1982 Aug DISC >A> + @ 20MG N 018029 001 Mar 30, 1982 Aug DISC

METOCLOPRAMIDE HYDROCHLORIDE TABLET, ORALLY DISINTEGRATING;ORAL METOCLOPRAMIDE HYDROCHLORIDE >D> AB NOVEL LABS INC EQ 5MG BASE A 202191 001 Aug 15, 2014 Aug CTEC >A> EQ 5MG BASE A 202191 001 Aug 15, 2014 Aug CTEC >D> EQ 10MG BASE A 202191 002 Aug 15, 2014 Aug CHRS >A> ! EQ 10MG BASE A 202191 002 Aug 15, 2014 Aug CHRS >D> METOZOLV ODT >D> AB +! SALIX PHARMS EQ 5MG BASE N 022246 001 Sep 04, 2009 Aug DISC >A> + @ EQ 5MG BASE N 022246 001 Sep 04, 2009 Aug DISC

MIDAZOLAM HYDROCHLORIDE INJECTABLE;INJECTION MIDAZOLAM HYDROCHLORIDE >D> AP AKORN INC EQ 5MG BASE/ML A 075481 001 Jun 30, 2000 Aug DISC >A> @ EQ 5MG BASE/ML A 075481 001 Jun 30, 2000 Aug DISC

>A> MIGALASTAT HYDROCHLORIDE >A> CAPSULE;ORAL >A> GALAFOLD >A> +! AMICUS THERAPS US EQ 123MG BASE N 208623 001 Aug 10, 2018 Aug NEWA

MORPHINE SULFATE SOLUTION;ORAL MORPHINE SULFATE >D> LANNETT CO INC 100MG/5ML N 201517 001 Jun 23, 2011 Aug DISC >A> @ 100MG/5ML N 201517 001 Jun 23, 2011 Aug DISC

Page 15 of 23 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

NAPROXEN TABLET;ORAL NAPROSYN >D> AB + ATNAHS PHARMA US 250MG N 017581 002 Mar 11, 1976 Aug DISC >A> + @ 250MG N 017581 002 Mar 11, 1976 Aug DISC >D> AB + 375MG N 017581 003 Jul 18, 1980 Aug DISC >A> + @ 375MG N 017581 003 Jul 18, 1980 Aug DISC

NAPROXEN SODIUM TABLET;ORAL >D> ANAPROX >D> AB + ATNAHS PHARMA US EQ 250MG BASE N 018164 001 Sep 04, 1980 Aug DISC >A> + @ EQ 250MG BASE N 018164 001 Sep 04, 1980 Aug DISC

NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE TABLET;ORAL SUMATRIPTAN AND NAPROXEN SODIUM >A> AB MYLAN PHARMS INC 500MG;EQ 85MG BASE A 090872 001 Sep 04, 2018 Aug NEWA

NEOSTIGMINE METHYLSULFATE SOLUTION;INTRAVENOUS NEOSTIGMINE METHYLSULFATE >A> AP RENAISSANCE SSA LLC 5MG/10ML (0.5MG/ML) A 210989 001 Aug 22, 2018 Aug NEWA >A> AP 10MG/10ML (1MG/ML) A 210989 002 Aug 22, 2018 Aug NEWA

NORGESTREL TABLET;ORAL OPILL >D> + @ LABORATOIRE HRA 0.075MG N 017031 001 Oct 23, 1973 Aug CMFD >A> + 0.075MG N 017031 001 Oct 23, 1973 Aug CMFD

OCTREOTIDE ACETATE INJECTABLE;INJECTION OCTREOTIDE ACETATE >A> AP USV NORTH AMERICA EQ 0.2MG BASE/ML A 203765 001 Sep 07, 2018 Aug NEWA >A> AP EQ 1MG BASE/ML A 203765 002 Sep 07, 2018 Aug NEWA

OSELTAMIVIR PHOSPHATE FOR SUSPENSION;ORAL OSELTAMIVIR PHOSPHATE >A> AB AMNEAL PHARMS NY EQ 6MG BASE/ML A 210186 001 Feb 27, 2018 Aug NEWA

>D> OXTRIPHYLLINE >D> TABLET, EXTENDED RELEASE;ORAL >D> CHOLEDYL SA >D> ! WARNER CHILCOTT LLC 400MG A 087863 001 May 24, 1983 Aug DISC >A> @ 400MG A 087863 001 May 24, 1983 Aug DISC

OXYBUTYNIN CHLORIDE TABLET;ORAL OXYBUTYNIN CHLORIDE >A> AB TULEX PHARMS INC 5MG A 210125 001 Sep 06, 2018 Aug NEWA

PACLITAXEL INJECTABLE;INJECTION PACLITAXEL >A> AP ACCORD HLTHCARE 6MG/ML A 205720 001 Aug 17, 2018 Aug NEWA

>A> PATISIRAN SODIUM >A> SOLUTION;INTRAVENOUS >A> ONPATTRO >A> +! ALNYLAM PHARMS INC EQ 10MG BASE/5ML (EQ 2MG N 210922 001 Aug 10, 2018 Aug NEWA BASE/ML)

PIOGLITAZONE HYDROCHLORIDE TABLET;ORAL PIOGLITAZONE HYDROCHLORIDE >D> AB DR REDDYS LABS LTD EQ 15MG BASE A 078383 001 Mar 12, 2013 Aug CAHN >D> AB EQ 30MG BASE A 078383 002 Mar 12, 2013 Aug CAHN >D> AB EQ 45MG BASE A 078383 003 Mar 12, 2013 Aug CAHN >A> AB NEOPHARMA EQ 15MG BASE A 078383 001 Mar 12, 2013 Aug CAHN

Page 16 of 23 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

PIOGLITAZONE HYDROCHLORIDE TABLET;ORAL PIOGLITAZONE HYDROCHLORIDE >A> AB EQ 30MG BASE A 078383 002 Mar 12, 2013 Aug CAHN >A> AB EQ 45MG BASE A 078383 003 Mar 12, 2013 Aug CAHN

PIPERACILLIN SODIUM; TAZOBACTAM SODIUM INJECTABLE;INJECTION PIPERACILLIN AND TAZOBACTAM >A> AP APOLLO PHARMS INC EQ 12GM BASE/VIAL;EQ 1.5GM A 207848 001 May 11, 2018 Aug NEWA BASE/VIAL ZOSYN >A> AP +! WYETH PHARMS EQ 2GM BASE/VIAL;EQ 250MG N 050684 001 Oct 22, 1993 Aug CAHN BASE/VIAL >A> AP +! EQ 3GM BASE/VIAL;EQ 375MG N 050684 002 Oct 22, 1993 Aug CAHN BASE/VIAL >A> AP +! EQ 4GM BASE/VIAL;EQ 500MG N 050684 003 Oct 22, 1993 Aug CAHN BASE/VIAL >A> AP +! EQ 36GM BASE/VIAL;EQ 4.5GM N 050684 004 Oct 22, 1993 Aug CAHN BASE/VIAL >D> AP +! WYETH PHARMS INC EQ 2GM BASE/VIAL;EQ 250MG N 050684 001 Oct 22, 1993 Aug CAHN BASE/VIAL >D> AP +! EQ 3GM BASE/VIAL;EQ 375MG N 050684 002 Oct 22, 1993 Aug CAHN BASE/VIAL >D> AP +! EQ 4GM BASE/VIAL;EQ 500MG N 050684 003 Oct 22, 1993 Aug CAHN BASE/VIAL >D> AP +! EQ 36GM BASE/VIAL;EQ 4.5GM N 050684 004 Oct 22, 1993 Aug CAHN BASE/VIAL ZOSYN IN PLASTIC CONTAINER >A> +! WYETH PHARMS EQ 40MG BASE/ML;EQ 5MG BASE/ML N 050750 001 Feb 24, 1998 Aug CAHN >A> +! EQ 60MG BASE/ML;EQ 7.5MG N 050750 002 Feb 24, 1998 Aug CAHN BASE/ML >A> +! EQ 4GM BASE/100ML;EQ 500MG N 050750 003 Feb 24, 1998 Aug CAHN BASE/100ML >D> +! WYETH PHARMS INC EQ 40MG BASE/ML;EQ 5MG BASE/ML N 050750 001 Feb 24, 1998 Aug CAHN >D> +! EQ 60MG BASE/ML;EQ 7.5MG N 050750 002 Feb 24, 1998 Aug CAHN BASE/ML >D> +! EQ 4GM BASE/100ML;EQ 500MG N 050750 003 Feb 24, 1998 Aug CAHN BASE/100ML

POSACONAZOLE >A> SOLUTION;INTRAVENOUS >A> NOXAFIL >A> +! MERCK SHARP DOHME 300MG/16.7ML (18MG/ML) N 205596 001 Mar 13, 2014 Aug CDFR >D> SOLUTION;IV (INFUSION) >D> NOXAFIL >D> +! MERCK SHARP DOHME 300MG/16.7ML (18MG/ML) N 205596 001 Mar 13, 2014 Aug CDFR

POTASSIUM CHLORIDE SOLUTION;ORAL POTASSIUM CHLORIDE >A> AA NOVEL LABS INC 20MEQ/15ML A 209786 001 Aug 29, 2018 Aug NEWA >A> AA 40MEQ/15ML A 209786 002 Aug 29, 2018 Aug NEWA TABLET, EXTENDED RELEASE;ORAL POTASSIUM CHLORIDE >A> AB2 STRIDES PHARMA 8MEQ A 210733 001 Aug 31, 2018 Aug NEWA >A> AB2 10MEQ A 210733 002 Aug 31, 2018 Aug NEWA

PREGABALIN TABLET, EXTENDED RELEASE;ORAL LYRICA CR >A> + PF PRISM CV 82.5MG N 209501 001 Oct 11, 2017 Aug CAHN >A> + 165MG N 209501 002 Oct 11, 2017 Aug CAHN >A> +! 330MG N 209501 003 Oct 11, 2017 Aug CAHN >D> + PFIZER INC 82.5MG N 209501 001 Oct 11, 2017 Aug CAHN >D> + 165MG N 209501 002 Oct 11, 2017 Aug CAHN >D> +! 330MG N 209501 003 Oct 11, 2017 Aug CAHN

RISEDRONATE SODIUM TABLET, DELAYED RELEASE;ORAL RISEDRONATE SODIUM >A> AB ZYDUS PHARMS USA INC 35MG A 203822 001 Sep 11, 2018 Aug NEWA

Page 17 of 23 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

ROFLUMILAST TABLET;ORAL DALIRESP >D> AB +! ASTRAZENECA PHARMS 500MCG N 022522 001 Feb 28, 2011 Aug CTEC >A> +! 500MCG N 022522 001 Feb 28, 2011 Aug CTEC ROFLUMILAST >D> AB MYLAN PHARMS INC 500MCG A 208257 001 Jul 13, 2018 Aug DISC >A> @ 500MCG A 208257 001 Jul 13, 2018 Aug DISC

ROLAPITANT HYDROCHLORIDE >A> EMULSION;INTRAVENOUS >A> VARUBI >A> + @ TERSERA THERAPS LLC EQ 166.5MG BASE/92.5ML (EQ N 208399 001 Oct 25, 2017 Aug CDFR 1.8MG BASE/ML) >D> EMULSION;IV (INFUSION) >D> VARUBI >D> + @ TERSERA THERAPS LLC EQ 166.5MG BASE/92.5ML (EQ N 208399 001 Oct 25, 2017 Aug CDFR 1.8MG BASE/ML)

ROMIDEPSIN >A> POWDER;INTRAVENOUS >A> ISTODAX >A> +! CELGENE 10MG/VIAL N 022393 001 Nov 05, 2009 Aug CDFR >D> POWDER;IV (INFUSION) >D> ISTODAX >D> +! CELGENE 10MG/VIAL N 022393 001 Nov 05, 2009 Aug CDFR

ROSUVASTATIN CALCIUM TABLET;ORAL ROSUVASTATIN CALCIUM >A> AB ALLIED 5MG A 079168 001 Jul 19, 2016 Aug CAHN >A> AB 10MG A 079168 002 Jul 19, 2016 Aug CAHN >A> AB 20MG A 079168 003 Jul 19, 2016 Aug CAHN >A> AB 40MG A 079168 004 Jul 19, 2016 Aug CAHN >D> AB PAR PHARM INC 5MG A 079168 001 Jul 19, 2016 Aug CAHN >D> AB 10MG A 079168 002 Jul 19, 2016 Aug CAHN >D> AB 20MG A 079168 003 Jul 19, 2016 Aug CAHN >D> AB 40MG A 079168 004 Jul 19, 2016 Aug CAHN

SEVELAMER CARBONATE TABLET;ORAL RENVELA >D> AB +! GENZYME 800MG N 022127 001 Oct 19, 2007 Aug CAHN >A> AB +! SANOFI 800MG N 022127 001 Oct 19, 2007 Aug CAHN

SIMVASTATIN TABLET;ORAL SIMVASTATIN >D> @ HISUN PHARM 10MG A 206557 001 Nov 13, 2017 Aug CAHN >D> @ 20MG A 206557 002 Nov 13, 2017 Aug CAHN >D> @ 40MG A 206557 003 Nov 13, 2017 Aug CAHN >D> @ 80MG A 206557 004 Nov 13, 2017 Aug CAHN >A> @ HISUN PHARM HANGZHOU 10MG A 206557 001 Nov 13, 2017 Aug CAHN >A> @ 20MG A 206557 002 Nov 13, 2017 Aug CAHN >A> @ 40MG A 206557 003 Nov 13, 2017 Aug CAHN >A> @ 80MG A 206557 004 Nov 13, 2017 Aug CAHN

SODIUM NITROPRUSSIDE INJECTABLE;INJECTION SODIUM NITROPRUSSIDE >D> AP APICORE US 25MG/ML A 209584 001 Aug 10, 2018 Aug CAHN >A> AP MEDICURE 25MG/ML A 209584 001 Aug 10, 2018 Aug CAHN >A> AP SOMERSET THERAPS LLC 25MG/ML A 210882 001 Aug 17, 2018 Aug NEWA >A> SOLUTION;INTRAVENOUS >A> NIPRIDE RTU IN SODIUM CHLORIDE 0.9% >A> +! EXELA PHARMA SCS LLC 10MG/50ML (0.2MG/ML) N 209387 002 Dec 07, 2017 Aug CDFR >A> +! 50MG/100ML (0.5MG/ML) N 209387 001 Mar 08, 2017 Aug CDFR >D> SOLUTION;IV (INFUSION) >D> NIPRIDE RTU IN SODIUM CHLORIDE 0.9% >D> +! EXELA PHARMA SCS LLC 10MG/50ML (0.2MG/ML) N 209387 002 Dec 07, 2017 Aug CDFR >D> +! 50MG/100ML (0.5MG/ML) N 209387 001 Mar 08, 2017 Aug CDFR

Page 18 of 23 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

STANOZOLOL TABLET;ORAL WINSTROL >D> @ LUNDBECK INC 2MG N 012885 001 May 14, 1984 Aug CRLD >A> + @ 2MG N 012885 001 May 14, 1984 Aug CRLD

>A> STIRIPENTOL >A> CAPSULE;ORAL >A> DIACOMIT >A> + BIOCODEX SA 250MG N 206709 001 Aug 20, 2018 Aug NEWA >A> +! 500MG N 206709 002 Aug 20, 2018 Aug NEWA >A> FOR SUSPENSION;ORAL >A> DIACOMIT >A> + BIOCODEX SA 250MG/PACKET N 207223 001 Aug 20, 2018 Aug NEWA >A> +! 500MG/PACKET N 207223 002 Aug 20, 2018 Aug NEWA

SULFADIAZINE TABLET;ORAL SULFADIAZINE >D> @ LILLY 500MG N 004122 002 Aug 26, 1941 Aug CRLD >A> + @ 500MG N 004122 002 Aug 26, 1941 Aug CRLD

TADALAFIL TABLET;ORAL ADCIRCA >D> AB +! ELI LILLY CO 20MG N 022332 001 May 22, 2009 Aug CTEC >A> AB2 +! 20MG N 022332 001 May 22, 2009 Aug CTEC CIALIS >D> AB +! LILLY 20MG N 021368 003 Nov 21, 2003 Aug CTEC >A> AB1 +! 20MG N 021368 003 Nov 21, 2003 Aug CTEC TADALAFIL >D> AB MYLAN PHARMS INC 20MG A 200630 001 Aug 03, 2018 Aug CTEC >A> AB2 20MG A 200630 001 Aug 03, 2018 Aug CTEC >D> AB TEVA PHARMS USA 20MG A 090141 004 May 22, 2018 Aug CTEC >A> AB1 20MG A 090141 004 May 22, 2018 Aug CTEC

>A> TAFENOQUINE SUCCINATE >A> TABLET;ORAL >A> ARAKODA >A> +! 60 DEGREES PHARMS EQ 100MG BASE N 210607 001 Aug 08, 2018 Aug NEWA

TALIGLUCERASE ALFA >A> POWDER;INTRAVENOUS >A> ELELYSO >A> +! PFIZER 200 UNITS/VIAL N 022458 001 May 01, 2012 Aug CDFR >D> POWDER;IV (INFUSION) >D> ELELYSO >D> +! PFIZER 200 UNITS/VIAL N 022458 001 May 01, 2012 Aug CDFR

TEDIZOLID PHOSPHATE >A> POWDER;INTRAVENOUS >A> SIVEXTRO >A> +! CUBIST PHARMS LLC 200MG/VIAL N 205436 001 Jun 20, 2014 Aug CDFR >D> POWDER;IV (INFUSION) >D> SIVEXTRO >D> +! CUBIST PHARMS LLC 200MG/VIAL N 205436 001 Jun 20, 2014 Aug CDFR

TELAVANCIN HYDROCHLORIDE >A> POWDER;INTRAVENOUS >A> VIBATIV >A> + @ THERAVANCE BIOPHARMA EQ 250MG BASE/VIAL N 022110 001 Sep 11, 2009 Aug CDFR >A> +! EQ 750MG BASE/VIAL N 022110 002 Sep 11, 2009 Aug CDFR >D> POWDER;IV (INFUSION) >D> VIBATIV >D> + @ THERAVANCE BIOPHARMA EQ 250MG BASE/VIAL N 022110 001 Sep 11, 2009 Aug CDFR >D> +! EQ 750MG BASE/VIAL N 022110 002 Sep 11, 2009 Aug CDFR

Page 19 of 23 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

TERIFLUNOMIDE TABLET;ORAL TERIFLUNOMIDE >A> AB TEVA PHARMS USA 7MG A 209700 001 Sep 04, 2018 Aug NEWA >A> AB 14MG A 209700 002 Sep 04, 2018 Aug NEWA

TESTOSTERONE ENANTHATE INJECTABLE;INJECTION TESTOSTERONE ENANTHATE >D> @ NEXUS PHARMS 200MG/ML A 040575 001 Jun 14, 2006 Aug CMFD >A> AO 200MG/ML A 040575 001 Jun 14, 2006 Aug CMFD

THIOTEPA >A> POWDER;INTRAVENOUS >A> TEPADINA >A> +! ADIENNE SA 15MG/VIAL N 208264 001 Jan 26, 2017 Aug CDFR >A> +! 100MG/VIAL N 208264 002 Jan 26, 2017 Aug CDFR >D> POWDER;IV (INFUSION) >D> TEPADINA >D> +! ADIENNE SA 15MG/VIAL N 208264 001 Jan 26, 2017 Aug CDFR >D> +! 100MG/VIAL N 208264 002 Jan 26, 2017 Aug CDFR

TICAGRELOR TABLET;ORAL BRILINTA >D> + ASTRAZENECA PHARMS 60MG N 022433 002 Sep 03, 2015 Aug CFTG >A> AB + 60MG N 022433 002 Sep 03, 2015 Aug CFTG >D> +! 90MG N 022433 001 Jul 20, 2011 Aug CFTG >A> AB +! 90MG N 022433 001 Jul 20, 2011 Aug CFTG >A> TICAGRELOR >A> AB WATSON LABS INC 60MG A 208390 001 Sep 04, 2018 Aug NEWA >A> AB 90MG A 208390 002 Sep 04, 2018 Aug NEWA

TIGECYCLINE POWDER;INTRAVENOUS TIGECYCLINE >A> AP AMNEAL PHARMS LLC 50MG/VIAL N 211158 001 Aug 02, 2018 Aug NEWA

TRABECTEDIN >A> POWDER;INTRAVENOUS >A> YONDELIS >A> +! JANSSEN PRODS 1MG/VIAL N 207953 001 Oct 23, 2015 Aug CDFR >D> POWDER;IV (INFUSION) >D> YONDELIS >D> +! JANSSEN PRODS 1MG/VIAL N 207953 001 Oct 23, 2015 Aug CDFR

TRETINOIN >A> LOTION;TOPICAL >A> ALTRENO >A> +! DOW PHARM 0.05% N 209353 001 Aug 23, 2018 Aug NEWA

VALACYCLOVIR HYDROCHLORIDE TABLET;ORAL VALACYCLOVIR HYDROCHLORIDE >D> AB DR REDDYS LABS LTD EQ 500MG BASE A 079012 001 May 24, 2010 Aug CAHN >D> AB EQ 1GM BASE A 079012 002 May 24, 2010 Aug CAHN >A> AB TIME-CAP LABS INC EQ 500MG BASE A 079012 001 May 24, 2010 Aug CAHN >A> AB EQ 1GM BASE A 079012 002 May 24, 2010 Aug CAHN

VALSARTAN TABLET;ORAL VALSARTAN >D> AB WATSON LABS INC 40MG A 090642 001 Jan 05, 2015 Aug DISC >A> @ 40MG A 090642 001 Jan 05, 2015 Aug DISC >D> AB 80MG A 090642 002 Jan 05, 2015 Aug DISC >A> @ 80MG A 090642 002 Jan 05, 2015 Aug DISC >D> AB 160MG A 090642 003 Jan 05, 2015 Aug DISC >A> @ 160MG A 090642 003 Jan 05, 2015 Aug DISC >D> AB 320MG A 090642 004 Jan 05, 2015 Aug DISC >A> @ 320MG A 090642 004 Jan 05, 2015 Aug DISC

Page 20 of 23 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

VORICONAZOLE TABLET;ORAL VORICONAZOLE >D> AB APPCO PHARMA LLC 50MG A 206762 001 May 24, 2016 Aug CAHN >D> AB 200MG A 206762 002 May 24, 2016 Aug CAHN >A> AB RISING PHARMS 50MG A 206762 001 May 24, 2016 Aug CAHN >A> AB 200MG A 206762 002 May 24, 2016 Aug CAHN

Page 21 of 23 ADDITIONS/DELETIONS FOR OTC DRUG PRODUCT LIST

ASPIRIN CAPSULE;ORAL >D> ASPIRIN >D> +! PLX PHARMA 325MG N 203697 001 Jan 14, 2013 Aug CTNA >A> VAZALORE >A> +! PLX PHARMA 325MG N 203697 001 Jan 14, 2013 Aug CTNA

CETIRIZINE HYDROCHLORIDE TABLET;ORAL CETIRIZINE HYDROCHLORIDE HIVES >D> UNIQUE PHARM LABS 10MG A 077829 002 Aug 26, 2009 Aug CHRS >A> ! 10MG A 077829 002 Aug 26, 2009 Aug CHRS >D> ZYRTEC ALLERGY >D> + J AND J CONSUMER INC 5MG N 019835 003 Nov 16, 2007 Aug DISC >A> + @ 5MG N 019835 003 Nov 16, 2007 Aug DISC >D> ZYRTEC HIVES RELIEF >D> + J AND J CONSUMER INC 5MG N 019835 005 Nov 16, 2007 Aug DISC >A> + @ 5MG N 019835 005 Nov 16, 2007 Aug DISC >D> +! 10MG N 019835 006 Nov 16, 2007 Aug DISC >A> + @ 10MG N 019835 006 Nov 16, 2007 Aug DISC

CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL SOLUTION;TOPICAL >A> SOLUPREP >A> +! 3M HEALTH CARE 2%;70% N 208288 001 Aug 08, 2018 Aug NEWA

GUAIFENESIN TABLET, EXTENDED RELEASE;ORAL GUAIFENESIN >A> GUARDIAN DRUG 600MG A 209215 001 Sep 06, 2017 Aug CAHN >A> 1.2GM A 209215 002 Sep 06, 2017 Aug CAHN >D> GUARDIAN PHARMS 600MG A 209215 001 Sep 06, 2017 Aug CAHN >D> 1.2GM A 209215 002 Sep 06, 2017 Aug CAHN

IBUPROFEN SUSPENSION;ORAL IBUPROFEN >A> GUARDIAN DRUG 100MG/5ML A 210149 001 Aug 17, 2018 Aug NEWA TABLET;ORAL IBUPROFEN >A> AIPING PHARM INC 200MG A 206990 001 Aug 21, 2018 Aug NEWA

LOPERAMIDE HYDROCHLORIDE; SIMETHICONE TABLET;ORAL LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE >A> PERRIGO R AND D 2MG;125MG A 209837 001 Sep 05, 2018 Aug NEWA

NICOTINE POLACRILEX GUM, CHEWING;BUCCAL >D> THRIVE >D> GLAXOSMITHKLINE CONS EQ 4MG BASE A 077656 001 Jun 19, 2007 Aug DISC >A> @ EQ 4MG BASE A 077656 001 Jun 19, 2007 Aug DISC

RANITIDINE HYDROCHLORIDE TABLET;ORAL RANITIDINE HYDROCHLORIDE >A> GRANULES INDIA LTD EQ 150MG BASE A 210243 001 Aug 20, 2018 Aug NEWA >A> EQ 150MG BASE A 210243 002 Aug 20, 2018 Aug NEWA

Page 22 of 23 CURRENT MONTH ADDS/DELETES LIST NOTE:

The List is sorted by Ingredient(s) and, within each grouping, by the Dosage Form; Route and then by trade name.

The individual product record contains the Therapeutic Equivalence Code, Reference Listed Drug symbol, Reference Standard Drug symbol, applicant holder, strength(s), New Drug Application number, product number, and approval date. The last two columns describe the action. The Action Month is the CS month the action occurred. The OB Action is the type of change that has occurred.

New ingredient(s), new dosage form; route(s), new trade names, and new product additions are preceded by >A> during the action month. The change month is the current CS month; the change code for new approvals is NEWA.

Changes to currently listed products will list two records. The deleted product record will be proceeded by >D>. The product record change addition being made will be preceded by >A>.

The change code description:

NEWA New drug product approval usually in the supplement month. CAHN** Applicant holder firm name has changed. CAIN Change. There has been a change in the Ingredient(s) name. All products will be deleted under the old name and all products will be added under the changed ingredient(s) name. CDFR Change. Dosage Form; Route of Administration. CFTG Change. A first time generic for the innovator product. A TE Code is added. CMFD Change. The product is moved from the Discontinued Section due to a change in marketing status. CMS1 Change. Miscellaneous addition to list. CMS2 Change. Miscellaneous deletion from list. CPOT Change. Potency amount/unit. CRLD Change. Reference Listed Drug. CHRS Change. Reference Standard. CTEC Change. Therapeutic Equivalence Code. CTNA Change. Trade Name. DISC Discontinued. The Rx or OTC listed product is not being marketed and will be moved to the discontinued section in the next edition.

**Note: The Cumulative Supplement (CS) currently displays a condensed 20 character collapsed applicant holder firm name and the Electronic Orange Book(EOB)query may display up to a 240 character full applicant holder firm name. An applicant holder firm name change usually changes both the collapsed name and long name. On accasion, only the long name is changed resulting in the CS displaying only the collapsed name for the >D> and >A> action. The new firm long name will display in the EOB query.

Page 23 of 23